Basit öğe kaydını göster

dc.contributor.authorAkpolat, I
dc.contributor.authorAkpolat, T
dc.contributor.authorDanaci, M
dc.contributor.authorBaris, YS
dc.contributor.authorKaya, N
dc.contributor.authorKandemir, B
dc.date.accessioned2020-06-21T15:53:28Z
dc.date.available2020-06-21T15:53:28Z
dc.date.issued1997
dc.identifier.issn0300-9742
dc.identifier.urihttps://doi.org/10.3109/03009749709065723
dc.identifier.urihttps://hdl.handle.net/20.500.12712/22675
dc.descriptionWOS: A1997YL08200013en_US
dc.descriptionPubMed: 9433411en_US
dc.description.abstractIn this report, we present a patient with BD, amyloidosis and end-stage-renal-disease and discuss the literature on BD and amyloidosis. Forty-four patients with BD and amyloidosis are described in the literature. The type of amyloid fibrils were studied in 27 of this 44 patients and all were AA. The interval between the onset of first symptom of BD and the diagnosis of amyloidosis ranged from one to 27 years. This clinical observation and AA type amyloid fibrils in BD suggest that amyloidosis is secondary to inflammation. Behcet's disease should be considered in the differential diagnosis of AA amyloidosis.en_US
dc.language.isoengen_US
dc.publisherScandinavian University Pressen_US
dc.relation.isversionof10.3109/03009749709065723en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBehcet's diseaseen_US
dc.subjectAA proteinen_US
dc.subjectamyloidosisen_US
dc.titleBehcet's disease and amyloidosis - Review of the literatureen_US
dc.typereviewen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume26en_US
dc.identifier.issue6en_US
dc.identifier.startpage477en_US
dc.identifier.endpage479en_US
dc.relation.journalScandinavian Journal of Rheumatologyen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster